GSA Capital Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

GSA Capital Partners’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,713	Closed	-$263K	–	1744
2024 Q1	$263K	Buy	+1,713	New	+$261K	0.02%	1288
2023 Q2	–	Sell	-1,825	Closed	-$283K	–	1628
2023 Q1	$283K	Buy	+1,825	New	+$287K	0.03%	1062

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

GSA Capital Partners's FBT Position: Q2 2024 in Review

GSA Capital Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2024, closing a stake of 1,713 shares — an estimated $263K sold.

GSA Capital Partners first reported a position in FBT in Q1 2023 and held it in 2 quarters. The position peaked at $283K in Q1 2023. 251 funds tracked by Wall St. Rank hold FBT as of Q2 2024.

GSA Capital Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2024 after selling out during the quarter.
GSA Capital Partners sold 1,713 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2024, an estimated $263K.
GSA Capital Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and held it in 2 quarters.
GSA Capital Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $283K in Q1 2023.
251 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2024.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.